Clinical, radiological, and functional assessment in psoriatic arthritis: Is it different from other inflammatory joint diseases?

Annals of the Rheumatic Diseases

Volumn 65, Issue SUPPL. 3, 2006, Pages

  Gladman, D D ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR ANTAGONIST; HLA B27 ANTIGEN; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GOUT; HISTOPATHOLOGY; HUMAN; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SACROILIITIS; SCORING SYSTEM;

ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; HEALTH STATUS INDICATORS; HUMANS; QUALITY OF LIFE; SPONDYLARTHROPATHIES;

EID: 33750314555     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.058453     Document Type: Conference Paper

References (26)

1. Gladman DD. Psoriatic arthritis. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, et al. Kelly's Textbook of Rheumatology, 7th edn. Philadelphia: WB Saunders, 2004;1155-64).
2. Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe HA. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 1992;19:1115-19.
3. Gladman DD, Anhorn KB, Schachter RK, Mervat H. HLA antigens in psoriatic arthritis. J Rheumatol 1986;13:586-92.
4. Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993;36:893-900.
5. Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003;30:260-8.
6. Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum, 2000;43, 1244-56.
7. Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ. Patterns of cytokine production in psoriatic synovium. J Rheumatol, 1998;25, 1544-52.
8. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003;111:821-31.
9. Bruce IN, Schentag C, Gladman DD. Hyperuricemia in psoriatic arthritis (PsA) does not reflect the extent of skin involvement. J Clin Rheumatol 2000;6:6-9.
10. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT. Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis. Genetic and gender effects. Clin Invest Med 1993;16:1-7.
11. Ory PA, Gladman DD, Mease PJ. Psoriatic arthritis and imaging. Ann Rheum Dis 2005;64(suppl 2):ii55-ii57.
12. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28:1842-6.
13. Rahman P, Nguyen E, Cheung C, Schentag CT, Gladman DD. Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol 2001;28:1041-4.
14. Taylor WJ, Gladman DD, Helliwell PS, Marchesoni A, Mease P, Mielants M. Classification criteria for psoriatic arthritis. Arthritis Rheum 2006;54:2665-73.
15. Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis 1998;57:135-40.
16. Duffy CM, Watanabe Duffy KN, Gladman DD, Brubacher BB, Buskila D, et al. Utilization of the Arthritis Impact Measurement Scales (AIMS) for patients with psoriatic arthritis. J Rheumatol 1992;19:1727-32.
17. Husted J, Gladman DD, Farewell VT, Long JA. Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with Psoriatic Arthritis. J Rheumatol 1996;23:1015-19.
18. Blackmore M, Gladman DD, Husted J, Long JA, Farewell VT. Measuring Health Status in Psoriatic Arthritis: The Health Assessment Questionnaire and its modification. J Rheumatol 1995;22:886-93.
19. Husted J, Gladman DD, Long JA, Farewell V. A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol 1995;13:439-44.
20. Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: A comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001;45:151-8.
21. Husted J, Gladman DD, Farewell VT, Long JA, Cook RJ. Validating the SF-36 health questionnaire in patients with Psoriatic Arthritis. J Rheumatol 1997;24:511-17.
22. Husted JA, Gladman DD, Cook RJ, Farewell VT. Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis (PsA). J Rheumatol 1998;25:2146-55.
23. Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, et al. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis Rheum 2005;52:1227-36.
24. Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, et al. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 2004;50:2264-72.
25. Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EH, for the ADEPT Study Group, et al. Adalimumab in the treatment of patients with moderately to severely active psoriatic arthritis: results of the ADEPT trial. Arthritis Rheum 2005;52:3279-89.
26. McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004;63:162-9.